Restasis and Venclexta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Venclexta (venetoclax). Common drug interactions include syncope among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Venclexta. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

On Jul, 16, 2026

63 people who take Restasis and Venclexta together, and have interactions are studied.

Restasis and Venclexta drug interactions.

What are the common drug interactions of Restasis and Venclexta, by gender? *:

female:

Syncope (loss of consciousness with an inability to maintain postural tone)
Tooth loss
Urinary tract infection
Visual impairment
Weight decreased
Fatigue (feeling of tiredness)
Diarrhoea
Pyrexia (fever)
White blood cell count decreased
Agitation (state of anxiety or nervous excitement)

male:

Death
White blood cell count decreased
Hospitalisation
Neutropenia (an abnormally low number of neutrophils)
Blood creatinine increased
Dehydration (dryness resulting from the removal of water)
Epistaxis (bleed from the nose)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatic enzyme increased

What are the common drug interactions of Restasis and Venclexta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

Death
Bone density decreased
Cardiac disorder
Dermatitis allergic (inflammation of the skin due allergic reaction)
Diarrhoea
Dizziness
Gastrointestinal motility disorder (abnormal intestinal contractions)
Haemorrhage (bleeding)
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
Hypertension (high blood pressure)

60+:

White blood cell count decreased
Death
Cataract (clouding of the lens inside the eye)
Disease progression
Neutropenia (an abnormally low number of neutrophils)
Abdominal pain upper
Blood creatinine increased
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 28 people, 44.44%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 15 people, 23.81%
Pain: 7 people, 11.11%
High Blood Pressure: 5 people, 7.94%
Depression: 5 people, 7.94%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 4 people, 6.35%
Nausea And Vomiting: 4 people, 6.35%
Nausea (feeling of having an urge to vomit): 4 people, 6.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 6.35%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Venclexta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously